How AI Search Is Recommending Medicare Supplement Insurance: Monthly Trends

Executive Summary

UnitedHealthcare Vision held the coverage lead in October 2026 with 82.8% valid recommendation coverage, 5.6 points clear of the next brand, Mutual of Omaha at 77.2%. The lead was stable rather than commanding at the top: the biggest mover this month was Cigna, which rose 3.6 points from 68.2% in September 2026 to 71.8% in October 2026, while UnitedHealthcare Vision, Mutual of Omaha, and State Farm each eased by less than two points. For brands outside the top tier, the story is not one of active decline but of a widening distance from the four names that now dominate AI recommendation coverage.

Against the full series baseline, the category has reordered sharply. Cigna has climbed 24.8 points from 47.0% in July 2026 to 71.8% in October 2026, a significant rise and the sharpest sustained gain among continuing brands. Mutual of Omaha is up 32.6 points from 44.6% to 77.2%, and State Farm is up 23.7 points from 34.7% to 58.4%. Each of those brands posted a small month-over-month softening from September into October, but their baseline-to-current positions remain substantially stronger than where the series began.

The largest baseline-to-current decliners are the parent carriers whose names were tracked in July and August 2026 but are no longer part of the tracked list in the current period. UnitedHealthcare, Humana, Aetna, and Anthem (Elevance Health) each stand at 0.0% valid recommendation coverage in October 2026, down 66.3, 51.6, 45.5, and 23.1 points respectively from the July baseline. Product-specific vision lines now occupy those positions: UnitedHealthcare Vision at 82.8%, Humana Vision at 35.7%, Aetna Vision Preferred at 32.2%, and Anthem Blue View Vision at 11.0%.

The month itself was quiet. Nothing moved enough to break the pattern set in September 2026, and the four leading names held their ground. The category-level result is the product of several smaller movements and a naming shift, not a single brand's surge.

Each monthly run begins with 800 prompt-surface observations (559 unique questions in July 2026, 585 in October 2026) across the benchmark's defined AI/search surface universe. Of those, all 800 mentioned a tracked brand or competitor in both months; 433 were relevant and 367 irrelevant in July 2026, and 311 relevant and 489 irrelevant in October 2026. The public metrics use the 415 observations (July 2026) and 255 observations (October 2026) that survive both qualification stages.

Key Findings

AI Response Inconsistency Alerts

Questions This Section Answers

• Which Medicare Supplement brands triggered factual inconsistencies across ChatGPT, Copilot, Gemini, and AI Overviews?
• Where did the Cigna network-status conflict and the Humana Vision provider-acceptance conflict originate?

The conflict audit detected 3 critical or high-severity factual inconsistencies across 4 AI platforms: ChatGPT, Copilot, Gemini, and AI Overviews.

Cigna

Two high-severity inconsistencies were detected for Cigna, both concerning Cigna's network status with ContactsDirect, both at 0.9 confidence. When asked "What insurance does ContactsDirect take?", ChatGPT stated that Cigna is listed as an in-network plan, citing ContactsDirect's customer service FAQ. AI Overviews, answering the same question, placed Cigna under out-of-network and other plans, citing ContactsDirect's vision insurance page and a Business Insider guide to buying contacts online with insurance. The two answers cannot both be correct: Cigna cannot be simultaneously in-network and out-of-network-only for the same provider.

A second conflict on the same topic and the same question involved ChatGPT and Gemini. ChatGPT again listed Cigna as an in-network plan citing the ContactsDirect FAQ, while Gemini listed Cigna as an out-of-network carrier, citing the ContactsDirect FAQ alongside ContactsDirect's out-of-network page and vision insurance page. The responses differ on whether Cigna participates in ContactsDirect's network, and both platforms drew at least partly on the same source page.

Humana Vision

One high-severity inconsistency was detected for Humana Vision at 0.9 confidence, concerning whether the brand is accepted by Metrolina Eye Associates. When asked "What insurance does Metrolina Eye Associates accept?", Copilot stated that the practice accepts Humana, listing it under accepted medical insurance alongside vision plans such as VSP and EyeMed, citing the practice's location pages. Gemini stated explicitly that the practice does not participate with Humana Vision, citing Metrolina Eye's provider reference sheet, financing page, and provider specialty document. One flagged source excerpt from the practice's financing page lists "Medical Plans ... Humana," which supports the Copilot side. The two claims cannot both be true.

Benchmark Context

Questions This Section Answers

• How did the qualified observation count and qualified surface breadth change between July and October 2026?
• Which benchmark-level metrics moved most as the qualified set contracted?

The report separates the raw collection universe from the qualified analysis set. Brand-level recommendation percentages are calculated within the qualified benchmark set.

Qualified surface breadth held steady at six canonical AI/search families across both months, meaning the benchmark's measurement footprint did not narrow even as the qualified observation count fell. The metrics below are calculated against that qualified set, not the raw 800-observation collection.

Benchmark-Level Metrics

The qualified set contracted for a third consecutive month, from 347 observations in August 2026 to 299 in September 2026 to 255 in October 2026. Within that smaller set, a larger share of answers took usable recommendation form: the valid recommendation shortlist share reached 86.7% in October, its highest level in the series.

AI Recommendation Trend

Questions This Section Answers

• How does the October 2026 brand ranking compare with the July 2026 baseline for Medicare Supplement coverage?
• Which brands gained or lost the most recommendation coverage across the series?

The category held its September shape, with a dominant leader, a strong second, and a mid-tier that is separating into winners and also-rans.

No brand moved enough in October 2026 to exceed normal month-to-month variation. The baseline-to-current reordering was driven by the combination of several movements and a shift in tracked brand names, not by a single brand's October result.

What Changed This Month

Questions This Section Answers

• Which brand posted the largest month-over-month gain in October 2026, and what moved with it?
• How did the vision product lines and the parent-carrier names shift between the two periods?

Cigna

Cigna added 3.6 points of valid recommendation coverage, from 68.2% in September 2026 to 71.8% in October 2026, the largest month-over-month gain in the category this period. Against the July 2026 baseline of 47.0%, the brand is up 24.8 points, a significant rise and a three-month upward streak. The October gain was not large enough on its own to register as a breakout month.

Placement strengthened alongside coverage. Cigna's top-three recommendation rate reached 29.8% (76 observations), up from 18.7% in September 2026, and its rank-one rate moved off zero to 0.4% (1 observation). Raw mention presence was 83.5%, up 6.2 points from the July baseline of 77.3%.

The distinction: Cigna is winning coverage and top-three placement at scale while rarely taking the first recommendation slot. Its 183 valid recommendations in October carried an average rank of 3.81. A single rank-one placement is not yet a pattern.

Highest-priority diagnostic: Which brands hold rank-one when Cigna appears in the top three, and which prompt types produce those placements?

UnitedHealthcare Vision

UnitedHealthcare Vision held the lead at 82.8% valid recommendation coverage in October 2026, down 0.1 points from 82.9% in September 2026 and up 82.8 points from the 0.0% recorded in the July 2026 baseline. The month-over-month change is flat by the benchmark's threshold.

Placement remained the strongest in the category. Top-three rate was 72.2% (184 observations), up from 61.5% in September 2026, and rank-one rate was 40.8% (104 observations), up from 35.1%. Raw mention presence was 96.1% (245 of 255 qualified observations).

The distinction: coverage held steady while placement improved, meaning the brand consolidated its position rather than expanding its footprint. The benchmark does not establish why AI systems favor the vision-specific product line over the parent name.

Highest-priority diagnostic: Which prompts and surfaces produce the product-line naming, and does the parent carrier still appear in answers outside the tracked list?

Mutual of Omaha

Mutual of Omaha remained second at 77.2% valid recommendation coverage in October 2026, down 0.7 points from 77.9% in September 2026 and up 32.6 points from 44.6% in the July 2026 baseline, a significant baseline-to-current gain. The month-over-month softening is within normal variation.

Placement advanced. Top-three rate rose to 54.5% (139 observations) from 50.2% in September 2026, and rank-one rate reached 11.4% (29 observations) from 7.0%. Raw mention presence was 79.2%.

The distinction: the brand gave up a fraction of coverage while improving both top-three and rank-one rates, which points to higher-quality placements inside a marginally smaller recommendation footprint. Net sentiment was 1.0, the highest in the category.

Highest-priority diagnostic: Which prompts moved from broad mention to top-three placement, and which brands lost those positions?

State Farm and Blue Cross Blue Shield

State Farm stood at 58.4% valid recommendation coverage in October 2026, down 1.1 points from 59.5% in September 2026 and up 23.7 points from 34.7% in the July 2026 baseline, a significant baseline-to-current gain. Its rank-one rate was 22.0% (56 observations), second only to UnitedHealthcare Vision. Raw mention presence was 62.7%, the lowest of the four leading brands but 18.8 points above its July baseline.

Blue Cross Blue Shield recorded 56.1% valid recommendation coverage in October 2026, up 1.9 points from 54.2% in September 2026 and up 2.4 points from 53.7% in the July 2026 baseline, a stable result across the series. Its raw mention presence fell 12.8 points from 79.5% to 66.7%, a double-digit decline, while top-three rate held near 21.6% and rank-one rate dropped 3.8 points to 2.0%.

The distinction for Blue Cross Blue Shield: fewer AI answers mention the brand, but the proportion that recommend it has held steady, so the coverage figure understates a narrowing visible footprint. For State Farm, the opposite pattern holds: strong rank-one strength sits behind a relatively modest presence rate.

Highest-priority diagnostic: For Blue Cross Blue Shield, which prompts stopped mentioning the brand. For State Farm, which surfaces award rank-one placement.

The Vision Product Lines and the Parent-Carrier Names

Aetna Vision Preferred recorded 32.2% valid recommendation coverage in October 2026, up 1.8 points from 30.4% in September 2026 and up 32.2 points from the July 2026 baseline. Humana Vision stood at 35.7%, up 1.3 points from 34.4% in September 2026 and up 35.7 points from baseline. Anthem Blue View Vision reached 11.0%, up 3.0 points from 8.0% in September 2026 and up 11.0 points from baseline. Each is a significant riser against its baseline.

The four parent-carrier names, Aetna, Humana, UnitedHealthcare, and Anthem (Elevance Health), each stand at 0.0% valid recommendation coverage in October 2026, down 45.5, 51.6, 66.3, and 23.1 points respectively from the July 2026 baseline. They are not part of the tracked company list in the current period.

At the smallest counts, Colonial Penn finished October 2026 at 0.0% coverage with no valid recommendations, down 0.2 points from the July baseline, and Bankers Life at 0.0% coverage with no valid recommendations, down 0.5 points. Both brands registered a single present observation in the period.

The distinction: the parent-carrier declines and the vision-line gains move together, but the benchmark does not establish that AI systems are renaming one brand as the other. The tracked company list changed; what still surfaces under parent names is outside the current measurement.

Highest-priority diagnostic: Which prompt formulations produce the product-line names versus the parent names, and on which surfaces does each appear?

Buyer-Intent Interpretation

Questions This Section Answers

• Which buyer-intent clusters produced qualified Medicare Supplement observations in October 2026?
• Which commercial questions remain unanswered because Pricing and Value and Multi-Brand Comparison captured no qualified observations?

All 255 qualified observations in October 2026 fell into the Brand Recommendation cluster. No qualified observations were captured in Pricing and Value or Multi-Brand Comparison. That means the public benchmark cannot yet answer the commercial questions Medicare Supplement buyers actually ask after the shortlist forms: how the options compare on cost, which carrier is positioned as better value, and who wins a head-to-head comparison. Those questions remain open for company-level analysis.

Brand Opportunity Summary

Questions This Section Answers

• Which Medicare Supplement brands show improving placement signals versus stable or falling presence signals?
• What is the highest-priority diagnostic for the leading brands and for those at 0.0% coverage?

The benchmark identifies where attention is warranted; a company-level analysis is needed to explain why.

Evidence Behind the Benchmark

The aggregate metrics are built from prompt-level observations covering the query, the AI surface, the recommendation outcome, rank, sentiment, and citations where the platforms expose them. Company-level analysis can go deeper into prompt, competitor, surface, and evidence-source patterns than the vertical-wide view allows. Source presence is not automatically treated as proof of causation, and a brand appearing in an AI answer is not the same as a brand being recommended.

About This Benchmark

This report is part of the LLM Authority Index AI Visibility Market Discovery research program, published by CiteWorks Studio.

• AI Visibility Industry Market Methodology
• AI Visibility Industry Market Metrics
• AI Visibility Industry Market Standards

Report-Specific Interpretation Notes

• Small-count movement: Brands with only one or two present observations, including Colonial Penn and Bankers Life, can show percentage shifts that reflect a single answer rather than a trend. These should be read as presence signals, not coverage movements.
• Qualified denominator vs raw collection: All percentages use the qualified observation count (255 in October 2026) as the denominator, not the raw 800 prompt-surface observations.
• Instrument continuity: The same measurement instrument, platform set, query-volume source, and qualification rules were used across all four months. The tracked company list changed between August and September 2026, moving four parent-carrier names to product-specific vision lines, and that naming change accounts for the parent brands' presence at 0.0% in the current period.
• Directional analysis: A month-over-month change identifies movement worth investigating. It does not by itself establish the cause of that movement, and the fact that parent-carrier names and vision product lines moved in opposite directions does not prove that one replaced the other in AI answers.

Next Step

The Public Benchmark Shows Where a Brand Is Winning or Losing. A Company-Level Audit Shows Why.

Beneath each aggregate percentage sit the questions that decide competitive position: which high-intent prompts are won and lost, which competitor takes the recommendation when a brand is passed over, what attributes AI systems attach to each option, and which external sources shape those answers. The October 2026 conflicts around Cigna's network status and Humana Vision's acceptance at a provider show how much turns on the specific sources these systems rely on.

A company-specific AI visibility audit maps those prompt, surface, competitor, ranking, sentiment, and evidence-source patterns into a prioritized visibility strategy. It converts the benchmark's directional signals into a plan for closing a gap or defending a lead.

Request an AI visibility audit